Tag: medicinal cannabis products
Althea enters the A$880m South African cannabis market
Australian cannabis company Althea has completed its first commercial shipment of medicinal cannabis products to Africann, its local partner in South Africa.
Althea CEO Joshua...
Cann Group receives $3.2M R&D refund for cannabis med manufacture
Medicinal cannabis supplier and manufacturer Cann Group Limited (ASX:CAN) received today a research and development (R&D) tax incentive refund amounting to $3.2 million.
The Australian...
AusCann’s Chilean JV to kick off crop cultivation with Khiron Life Sciences
Australian medicinal cannabis company AusCann has announced that its 50:50 Chilean joint venture, DayaCann, will commence its first third party cannabis cultivation activity with Canadian...
Cann Group inks broad R&D agreement with CSIRO
Listed medicinal cannabis company Cann Group has inked a broad, multiyear agreement with CSIRO that extends the research and development collaboration between the two parties.
The...
Cronos Australia receives manufacturing licence Â
Cronos Australia has been granted a medicinal cannabis Manufacture License by the Australian Office of Drug Control.
Mike Gorenstein, CEO of Cronos Group said the...
Featured Article
Sydney to spotlight the latest in manufacturing at AMW 2024
With the Australian Manufacturing Week (AMW) 2024 fast approaching, Sydney is set to become the epicentre of groundbreaking innovations in the advanced manufacturing sector.Â
